We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 10, 2022

Effect of Castration Status on Docetaxel-Related Adverse Events in Patients With Metastatic Prostate Cancer

The Prostate

 

Additional Info

The Prostate
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer
Prostate 2022 Jun 29;[EPub Ahead of Print], T Yanagisawa, T Kimura, K Hata, S Narita, S Hatakeyama, Y Enei, M Atsuta, K Mori, K Obayashi, K Yoshihara, Y Kondo, T Oguchi, I Sadakane, T Habuchi, C Ohyama, SF Shariat, S Egawa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading